Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8982 |
High Similarity |
NPD7472 |
Approved |
0.8922 |
High Similarity |
NPD7054 |
Approved |
0.8869 |
High Similarity |
NPD7074 |
Phase 3 |
0.8824 |
High Similarity |
NPD7808 |
Phase 3 |
0.8765 |
High Similarity |
NPD7251 |
Discontinued |
0.8713 |
High Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.8706 |
High Similarity |
NPD6797 |
Phase 2 |
0.8663 |
High Similarity |
NPD8312 |
Approved |
0.8663 |
High Similarity |
NPD8313 |
Approved |
0.8639 |
High Similarity |
NPD3818 |
Discontinued |
0.8439 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.8383 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.8266 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.8214 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8198 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8198 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8198 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.8171 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.8047 |
Intermediate Similarity |
NPD5402 |
Approved |
0.8036 |
Intermediate Similarity |
NPD1934 |
Approved |
0.8022 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.8012 |
Intermediate Similarity |
NPD1653 |
Approved |
0.8011 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.8 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7988 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7988 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7941 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7882 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7882 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7862 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7844 |
Intermediate Similarity |
NPD5403 |
Approved |
0.784 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7821 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7811 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7791 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7771 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7759 |
Intermediate Similarity |
NPD5494 |
Approved |
0.775 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7747 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7746 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7725 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7679 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7674 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7654 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.764 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7624 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7602 |
Intermediate Similarity |
NPD7783 |
Phase 2 |
0.7602 |
Intermediate Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.76 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7598 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.759 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7572 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7571 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7529 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7514 |
Intermediate Similarity |
NPD37 |
Approved |
0.7514 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7514 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7514 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7513 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7486 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7486 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7486 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7485 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7474 |
Intermediate Similarity |
NPD8320 |
Phase 1 |
0.7474 |
Intermediate Similarity |
NPD8319 |
Approved |
0.7472 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7455 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.744 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7423 |
Intermediate Similarity |
NPD7698 |
Approved |
0.7423 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.7423 |
Intermediate Similarity |
NPD7697 |
Approved |
0.7412 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7389 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7386 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7381 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7374 |
Intermediate Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.7374 |
Intermediate Similarity |
NPD7874 |
Approved |
0.7365 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.736 |
Intermediate Similarity |
NPD7701 |
Phase 2 |
0.7358 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7358 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7358 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7358 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7358 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7358 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7358 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7358 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7356 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7353 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7353 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7341 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7341 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7333 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7329 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7326 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7326 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7318 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7305 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7305 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7296 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.7296 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.7282 |
Intermediate Similarity |
NPD6823 |
Phase 2 |
0.7278 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7262 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7254 |
Intermediate Similarity |
NPD7699 |
Phase 2 |
0.7254 |
Intermediate Similarity |
NPD7700 |
Phase 2 |
0.725 |
Intermediate Similarity |
NPD7801 |
Approved |
0.7246 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7245 |
Intermediate Similarity |
NPD7680 |
Approved |
0.7241 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7239 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7222 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7216 |
Intermediate Similarity |
NPD7237 |
Clinical (unspecified phase) |
0.7215 |
Intermediate Similarity |
NPD1091 |
Approved |
0.7212 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7212 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7209 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7202 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.72 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7186 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7152 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7152 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7151 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7143 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7119 |
Intermediate Similarity |
NPD6844 |
Discontinued |
0.7118 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.711 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7099 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7098 |
Intermediate Similarity |
NPD6534 |
Approved |
0.7098 |
Intermediate Similarity |
NPD6535 |
Approved |
0.7083 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7083 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7081 |
Intermediate Similarity |
NPD3225 |
Approved |
0.7076 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7063 |
Intermediate Similarity |
NPD9717 |
Approved |
0.705 |
Intermediate Similarity |
NPD7584 |
Approved |
0.7047 |
Intermediate Similarity |
NPD6213 |
Phase 3 |
0.7047 |
Intermediate Similarity |
NPD6214 |
Clinical (unspecified phase) |
0.7047 |
Intermediate Similarity |
NPD6212 |
Phase 3 |
0.7037 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7033 |
Intermediate Similarity |
NPD5619 |
Clinical (unspecified phase) |
0.703 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7019 |
Intermediate Similarity |
NPD8155 |
Clinical (unspecified phase) |
0.7018 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7017 |
Intermediate Similarity |
NPD919 |
Approved |
0.6982 |
Remote Similarity |
NPD3748 |
Approved |
0.6976 |
Remote Similarity |
NPD7930 |
Approved |
0.6957 |
Remote Similarity |
NPD3926 |
Phase 2 |
0.6951 |
Remote Similarity |
NPD9494 |
Approved |
0.6946 |
Remote Similarity |
NPD943 |
Approved |
0.6944 |
Remote Similarity |
NPD5353 |
Approved |
0.6939 |
Remote Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.6931 |
Remote Similarity |
NPD7585 |
Approved |
0.6928 |
Remote Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.6928 |
Remote Similarity |
NPD411 |
Approved |
0.6923 |
Remote Similarity |
NPD7097 |
Phase 1 |
0.6919 |
Remote Similarity |
NPD7784 |
Clinical (unspecified phase) |
0.6914 |
Remote Similarity |
NPD2533 |
Approved |
0.6914 |
Remote Similarity |
NPD2532 |
Approved |
0.6914 |
Remote Similarity |
NPD2534 |
Approved |
0.6909 |
Remote Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.6905 |
Remote Similarity |
NPD6355 |
Discontinued |
0.6894 |
Remote Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.6882 |
Remote Similarity |
NPD4308 |
Phase 3 |
0.6881 |
Remote Similarity |
NPD7583 |
Approved |
0.6879 |
Remote Similarity |
NPD8166 |
Discontinued |
0.6872 |
Remote Similarity |
NPD6385 |
Approved |
0.6872 |
Remote Similarity |
NPD6386 |
Approved |
0.6869 |
Remote Similarity |
NPD8285 |
Discontinued |
0.6867 |
Remote Similarity |
NPD3027 |
Phase 3 |
0.6852 |
Remote Similarity |
NPD1608 |
Approved |
0.6848 |
Remote Similarity |
NPD1247 |
Approved |
0.6848 |
Remote Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.6845 |
Remote Similarity |
NPD1240 |
Approved |
0.6834 |
Remote Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.6818 |
Remote Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.6818 |
Remote Similarity |
NPD4420 |
Approved |
0.681 |
Remote Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.6789 |
Remote Similarity |
NPD7038 |
Approved |
0.6789 |
Remote Similarity |
NPD7039 |
Approved |
0.6788 |
Remote Similarity |
NPD1019 |
Discontinued |
0.678 |
Remote Similarity |
NPD6273 |
Approved |
0.6771 |
Remote Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.6765 |
Remote Similarity |
NPD6653 |
Approved |
0.6765 |
Remote Similarity |
NPD1607 |
Approved |
0.6754 |
Remote Similarity |
NPD7549 |
Discontinued |
0.6744 |
Remote Similarity |
NPD6100 |
Approved |
0.6744 |
Remote Similarity |
NPD6099 |
Approved |
0.6742 |
Remote Similarity |
NPD920 |
Approved |
0.6737 |
Remote Similarity |
NPD5953 |
Discontinued |
0.673 |
Remote Similarity |
NPD9493 |
Approved |
0.6727 |
Remote Similarity |
NPD3267 |
Approved |
0.6727 |
Remote Similarity |
NPD3266 |
Approved |
0.6726 |
Remote Similarity |
NPD6798 |
Discontinued |
0.6725 |
Remote Similarity |
NPD4978 |
Clinical (unspecified phase) |
0.6723 |
Remote Similarity |
NPD642 |
Clinical (unspecified phase) |
0.672 |
Remote Similarity |
NPD7286 |
Phase 2 |
0.6705 |
Remote Similarity |
NPD2344 |
Approved |
0.6705 |
Remote Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.6698
|
Remote Similarity |
NPD8059 |
Phase 3 |